Mike Wilson: What is Causing the Market Rally?

Mike Wilson: What is Causing the Market Rally?

As equities enjoy their best week since the summer highs in June, investors seem at the mercy of powerful market trends, so when might these trends take a turn to the downside?


----- Transcript -----


Welcome to Thoughts on the Market. I'm Mike Wilson, Chief Investment Officer and Chief U.S. Equity Strategist for Morgan Stanley. Along with my colleagues, bringing you a variety of perspectives, I'll be talking about the latest trends in the financial marketplace. It's Monday, October 24th, at 11:30 a.m. in New York. So let's get after it.


Last week, we made a tactically bullish call for U.S. equities, and stocks did not disappoint us. The S&P 500 had its best week since June 24th, which was the beginning of the big summer rally. As a reminder, this is a tactical call based almost purely on technicals rather than fundamentals, which remain unsupportive of higher equity prices over the next 3 to 6 months. Furthermore, the price action of the markets has become more technical than normal, and investors are forced to do things they don't want to, both on the upside and the downside. Witness September, which resulted in the worst month for U.S. equities since the COVID lockdowns in March of 2020. The same price action can happen now on the upside, and one needs to respect that in the near term, in our view.


As noted last week, the 200 week moving average is a powerful technical support level for stocks, particularly in the absence of an outright recession, which we don't have yet. While some may argue a recession is inevitable over the next 6 to 12 months, the market will not price it, in our view, until it's definitive. The typical signal required for that can only come from the jobs market. While nonfarm payrolls is a lagging indicator that gets revised later, the equity market tends to be focused on it. More specifically, it usually takes a negative payroll reading for the market to fully price a recession. Today, that number is a positive 265,000, and it's unlikely we get a negative payroll number in the next month or two. Of course, we also appreciate the fact that if one waits for such data to arrive, the opportunity to trade it will be missed. The question is one of timing. In the absence of hard data from either companies cutting guidance significantly for 2023 or unemployment claims spiking, the door is left open for a tactical trade higher before reality sets in.


Finally, as we begin the transition from fire to ice, falling inflation expectations could lead to a period of falling interest rates that may be interpreted by the equity market as bullish, until the reality of what that means for earnings is fully revealed. Given the strong technical support just below current levels, the S&P 500 can continue to rally toward 4000 or 4150 in the absence of capitulation from companies on 2023 earnings guidance. Conversely, should interest rates remain sticky at current levels, all bets are off on how far this equity rally can go beyond current prices. As a result, we stay tactically bullish as we enter the meat of what is likely to be a sloppy earnings season. We just don't have the confidence that there will be enough capitulation on 2023 earnings to take 2023 earnings per share forecasts down in the manner that it takes stocks to new lows. Instead, our base case is, that happens in either December when holiday demand fails to materialize or during fourth quarter earnings season in January and February, when companies are forced to discuss their outlooks for 2023 decisively. In the meantime, enjoy the rally.


Thanks for listening. If you enjoy Thoughts on the Market, please take a moment to rate and review us on the Apple Podcasts app. It helps more people to find the show.

Episoder(1515)

Special: Access & Opportunity Preview

Special: Access & Opportunity Preview

Morgan Stanley's Carla Harris talks with Charles Hudson, founder and Managing Partner at Precursor Ventures, a seed-stage investor bringing an institutional perspective to startups in the earliest stages of their development.

26 Jul 20194min

Michael Zezas: The Fed Rate Cut Debate for Bond Investors

Michael Zezas: The Fed Rate Cut Debate for Bond Investors

On today’s podcast, Head of Public Policy and Municipal Strategy Michael Zezas considers the debate between the consensus view of a potential 25 basis point Fed rate cut vs a 50 basis point cut.

24 Jul 20192min

Mike Wilson: Weighing a Potential Fed Rate Cut

Mike Wilson: Weighing a Potential Fed Rate Cut

On today’s podcast, Chief Investment Officer Mike Wilson says what matters for markets now isn't how much the Fed or other central banks could cut—but why they would cut.

22 Jul 20193min

Andrew Sheets: 3 Consensus Views Worth Questioning

Andrew Sheets: 3 Consensus Views Worth Questioning

On today’s podcast, Chief Cross-asset Strategist Andrew Sheets digs into three key debates around central bank policy expectations, valuations and investor sentiment.

19 Jul 20194min

Michael Zezas: 2020 Election: How Likely Is Medicare-for-All?

Michael Zezas: 2020 Election: How Likely Is Medicare-for-All?

On today’s podcast, Head of U.S. Public Policy research Michael Zezas asks “Would a Democratic presidential win mean the end of the road for private health care insurance?

17 Jul 20192min

Mike Wilson: For the S&P 500, Breaking Out Is Hard to Do

Mike Wilson: For the S&P 500, Breaking Out Is Hard to Do

On today’s podcast, Chief Investment Officer Mike Wilson says a sustained breakout above 3,000 has eluded the S&P 500. Will the Fed’s potential rate cut be the catalyst?

15 Jul 20194min

Andrew Sheets: A Second (and Third) Opinion for Equity Markets

Andrew Sheets: A Second (and Third) Opinion for Equity Markets

On this episode, Chief Cross-Asset Strategist Andrew Sheets examines the models for stock performance, and how they are all leading to a similar conclusion.

12 Jul 20194min

Michael Zezas: Healthcare Reform - Here We Go Again?

Michael Zezas: Healthcare Reform - Here We Go Again?

On today’s podcast, as the 2020 Election nears, healthcare reform is a central debate once again. Head of U.S. Public Policy Michael Zezas shares potential outcomes for patients—and investors.

10 Jul 20192min

Populært innen Business og økonomi

stopp-verden
dine-penger-pengeradet
lydartikler-fra-aftenposten
e24-podden
rss-penger-polser-og-politikk
rss-borsmorgen-okonominyhetene
finansredaksjonen
rss-vass-knepp-show
livet-pa-veien-med-jan-erik-larssen
pengepodden-2
tid-er-penger-en-podcast-med-peter-warren
morgenkaffen-med-finansavisen
okonomiamatorene
utbytte
rss-markedspuls-2
lederpodden
rss-sunn-okonomi
rss-fri-kontantstrom
rss-impressions-2
aksjepodden